Jecure Therapeutics launches with $20mm Series A round
Versant Ventures has launched liver disease start-up Jecure Therapeutics and funded the company with $20mm in Series A money.
- Venture Financing
Please contact Sales at: (212) 520-2765 or email [email protected]
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.